Taiko Pharmaceutical Co.,Ltd.

TSE:4574.T

392 (JPY) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income -4,869-8,8875,374.273,504.3261,985.9831,552.7451,491.0311,191.5252,758.6182,553.6721,100.561414.551-1,995.8922,589.506691.115599.671
Depreciation & Amortization 737941472.871495.204460.891453.657444.846350.524280.61258.692250.528258.841241.264212.214176.43164.336
Deferred Income Tax 0000000000000000
Stock Based Compensation 0000000000000000
Change In Working Capital 2,2014,500-6,379.37757.58851.01-1,515.8791,002.46-604.871-641.137671.575-136.535-830.896340.517-683.254209.813-247.863
Accounts Receivables 0000-27400000000000
Inventory 1,2573,222-4,380.01-484.733-16.295-139.349372.02423.099-462.229-292.229-38.298173.072109.485-668.163-114.425-134.574
Accounts Payables 0000000000000000
Other Working Capital 9441,278-1,999.367542.321341.305-1,376.53630.44-1,027.97-178.908963.804-98.237-1,003.968231.032-15.091324.238-113.289
Other Non Cash Items -631,851-984.666-563.827-749.702-550.17-240.723-559.502-1,707.71105.48-121.648691.469-276.123-222.22560.501-254.324
Operating Cash Flow -1,994-1,595-1,516.9023,493.2911,748.182-59.6472,697.614377.676690.3813,589.4191,092.906533.965-1,690.2341,896.2411,137.859261.82
Investing Activities:
Investments In Property Plant And Equipment -84-1,600-2,225.301-220.26-505.607-138.109-122.297-3,756.383-2,881.497-303.83-211.895-180.572-197.942-225.097-563.947-162.319
Acquisitions Net -9-107-50.928-61.971302.1870100000001,049.640052.886
Purchases Of Investments -234-8-562.366-262.665-801.890-50-200000-0.81-1.379-1.351-1.384
Sales Maturities Of Investments 5179378.89631.93445.6023-10.6990411.472000.54929.093193.1966.284181.567
Other Investing Activites 00-0.00164.476212.90121.26110.6981,140.572-284.65-316.836225.45762.26-51.467-77.692-5.226-62.633
Investing Cash Flow 190-1,622-2,759.7-448.486-746.807-113.848-72.298-2,635.811-2,754.675-620.66613.562-117.763828.514-110.972-564.248.117
Financing Activities:
Debt Repayment -923-316-26.0980-178.49100-14.069-14.922000-16.994000
Common Stock Issued 0101222.498486.787178.841193.5041,459.583172.256144.486205.94245.46436.74581.5860043.771
Common Stock Repurchased 04,957-0.077-540.368-0.00300-0.075-641.6560-285.6560-0.016-0.18800
Dividends Paid 0-782-845.772-499.154-498.536-282.701-195.671-319.917-324.735-190.542-194.064-62.496-126.124-21.26-10.63-10.5
Other Financing Activities -74-1-0.001-28.48716015.254-14.88626.08511.3994.29-17.531.45-0.001-12.083-2.425-300
Financing Cash Flow -9973,959-649.45-581.222-338.189-73.9431,249.026-135.72-825.42819.69-451.786-24.301-61.549-33.531-13.055-266.729
Other Information:
Effect Of Forex Changes On Cash 7682-21.748-10.42-17.877-8.055-68.151-47.866105.586100.38739.001-10.948-58.6467.911-52.023-53.486
Net Change In Cash -2,724823-4,947.8022,453.162645.307-255.4953,806.192-2,441.721-2,784.1373,088.83679.4380.952-981.9151,759.65508.541-50.278
Cash At End Of Period 2,7975,5214,698.1789,645.987,192.8186,547.5116,803.0062,996.8145,438.5358,222.6725,133.8424,454.4424,073.495,055.4053,295.7552,787.214